The gaseous compound carbon monoxide (CO) has been identified as an important endogenous biological messenger in brain and is a major component in regulation of cerebrovascular circulation in newborns. CO is produced endogenously by catabolism of heme to CO, free iron, and biliverdin during enzymatic degradation of heme by heme oxygenase (HO). The present study was designed to test the hypothesis that endogenously produced CO contributes to hypotension-induced vasodilation of cerebral arterioles. Experiments used anesthetized piglets with implanted, closed cranial windows. Topical application of the HO substrate heme-L-lysinate caused dilation of pial arterioles that was blocked by a metal porphyrin inhibitor of HO, chromium mesoporphyrin (CrMP). In normotensive piglets (arterial pressure 64 Ϯ 4 mmHg), CrMP did not cause vasoconstriction of pial arterioles but rather a transient dilation. Hypotension (50% of basal blood pressure) increased cerebral CO production and dilated pial arterioles from 66 Ϯ 2 to 92 Ϯ 7 m. In hypotensive piglets, topical CrMP or intravenous tin protoporphyrin decreased cerebral CO production and produced pial arteriolar constriction to normotensive diameters. In additional experiments, because prostacyclin and nitric oxide (NO) are also key dilators that can contribute to cerebrovascular dilation, we held their levels constant. NO/prostacyclin clamp was accomplished with continuous, simultaneous application of indomethacin, N -nitro-L-arginine, and minimal dilatory concentrations of iloprost and sodium nitroprusside. With constant NO and prostacyclin, the transient dilator and prolonged constrictor responses to CrMP of normotensive and hypotensive piglets, respectively, were the same as when NO and prostaglandins were not held constant. These data suggest that endogenously produced CO contributes to cerebrovascular dilation in response to reduced perfusion pressure. heme oxygenase; autoregulation; pial arterioles; newborn CARBON MONOXIDE (CO) is an autocrine and paracrine vasodilator in cerebral and systemic circulations, and endogenously produced CO can play a role in the regulation of basal tone in resistance vessels throughout the body (24, 25). CO is produced physiologically by catabolism of heme to CO, free iron, and biliverdin during enzymatic degeneration of heme by heme oxygenase (HO) (25). The constitutive HO isoform heme oxygenase-2 (HO-2) is highly expressed in the newborn piglet brain (28), and piglet cerebral microvessels produce CO at rates higher than other tissues our laboratory has examined (24). HO-2 expression has been found to be regulated only by steroids (25). Endogenous CO can be produced in high enough concentration to cause vasodilation (7, 30). The vasodilator effect of CO has been attributed to both the cGMP/PKG signaling pathway (27) and activation of Ca 2ϩ -activated K ϩ (K Ca ) channels (14). CO causes smooth muscle hyperpolarization via activation of large-conductance K Ca channels (39). CO increases the Ca 2ϩ sensitivity of K Ca channels (14, 39) and may also decrease the production of vasoconstrictors such as endothelin or cytochrome P-450-derived products (8). CO contributes to cerebrovascular dilation caused by excitatory amino acids (9, 24) and thus joins other autocrine and paracrine dilators such as nitric oxide (NO) and prostaglandins in control of cerebral vascular tone. Furthermore, there are interactions among the three (12, 21) .
CARBON MONOXIDE (CO) is an autocrine and paracrine vasodilator in cerebral and systemic circulations, and endogenously produced CO can play a role in the regulation of basal tone in resistance vessels throughout the body (24, 25) . CO is produced physiologically by catabolism of heme to CO, free iron, and biliverdin during enzymatic degeneration of heme by heme oxygenase (HO) (25) . The constitutive HO isoform heme oxygenase-2 (HO-2) is highly expressed in the newborn piglet brain (28) , and piglet cerebral microvessels produce CO at rates higher than other tissues our laboratory has examined (24) . HO-2 expression has been found to be regulated only by steroids (25) . Endogenous CO can be produced in high enough concentration to cause vasodilation (7, 30) . The vasodilator effect of CO has been attributed to both the cGMP/PKG signaling pathway (27) and activation of Ca 2ϩ -activated K ϩ (K Ca ) channels (14) . CO causes smooth muscle hyperpolarization via activation of large-conductance K Ca channels (39) . CO increases the Ca 2ϩ sensitivity of K Ca channels (14, 39) and may also decrease the production of vasoconstrictors such as endothelin or cytochrome P-450-derived products (8) . CO contributes to cerebrovascular dilation caused by excitatory amino acids (9, 24) and thus joins other autocrine and paracrine dilators such as nitric oxide (NO) and prostaglandins in control of cerebral vascular tone. Furthermore, there are interactions among the three (12, 21) .
Prostanoids contribute to regulation of the cerebral microcirculation in a variety of ways in newborn pigs. Prostacyclin contributes to the sustained vasodilation that allows maintenance of cerebral blood flow during severe hypotension in newborn pigs (20) . Endothelial prostacyclin can act as a permissive factor in cerebral microvascular smooth muscle, allowing dilation in response to another stimulus (22) . The synthesis of the prostanoid or NO need not be augmented by the stimulus to allow the response to occur, because both prostacyclin and NO play permissive roles in allowing dilation to CO (21) . Therefore, constrictions caused by inhibiting production of prostacyclin and/or NO could be caused, at least in part, by removing the ability of CO to produce dilation.
The goal of the present study was to address the hypothesis that HO-derived CO contributes to cerebrovascular vasodilation in response to hemorrhagic hypotension. We also investigated whether enhanced production of prostacyclin and/or NO was necessary for dilation to hypotension to occur.
MATERIALS AND METHODS
All procedures that involved animals were reviewed and approved by the Animal Care and Use Committee of the University of Tennessee Health Science Center. Newborn pigs (1-3 days old) were anesthetized with ketamine hydrochloride (33 mg/kg im) and acepromazine (3.3 mg/kg im) and maintained on ␣-chloralose (50 mg/kg iv). A catheter was inserted into a femoral artery to monitor blood pressure and heart rate and to collect blood for measurements of PCO 2, PO2, and pH. A second catheter was placed in a femoral vein for anesthetic and fluid administration. The trachea was cannulated, and the animals were mechanically ventilated and supplemented with O 2, if needed, to maintain arterial pH, PCO2, and PO2 within the normal range. A heating pad was used to maintain the animals at 37.5-38.5°C, which was monitored with a rectal probe.
Cranial window placement and pial arteriolar monitoring. The scalp was surgically removed, and a 2-cm-diameter craniotomy was made over the parietal cortex. The dura was incised and reflected over the bone to prevent contact between the brain surface and the cut edge of the bone. A stainless steel and glass window was implanted into the hole and cemented sequentially with bone wax and dental acrylic. This window consisted of three parts: a stainless steel ring, a circular glass coverslip, and three ports consisting of 17-gauge hypodermic needles attached to three precut holes in the stainless steel ring. The space under the window was filled with artificial cerebrospinal fluid (aCSF: 150 meq/l Na ϩ , 3 meq/l K ϩ , 2.5 meq/l Ca 2ϩ , 1.2 meq/l Mg 2ϩ , 132 meq/l Cl Ϫ , 3.7 mM glucose, 6 mM urea, and 25 meq/l HCO 3 Ϫ ; pH ϳ7.33, PCO 2 46 mmHg, PO2 43 mmHg, 37°C) through needles incorporated into the sides of the window. aCSF could be injected and samples collected from needle ports on the sides of the window. The volume of fluid directly beneath the window was 350 l and was contiguous with the periarachnoid space. Pial vessels were observed with a dissecting microscope. Diameters were measured with a video micrometer coupled to a television camera mounted on the microscope and a video monitor.
Chemicals. CO was purchased as compressed gas (99.5%). Water was saturated with CO to produce a 10 Ϫ3 M stock solution. The stock was diluted in aCSF from 10 Ϫ7 to 10 Ϫ5 M. Water-soluble indomethacin (indomethacin trihydrate) was a gift from MerckSharp & Dohme Research Laboratories (Rahway, NJ). Iloprost was a gift from Schering (Berlin, Germany) or was purchased from Cayman Chemical (Ann Arbor, MI). The HO substrate heme-L-lysinate (HLL) was prepared using methods described by Tenhunen et al. (32) and was stored at Ϫ30°C. HLL stock solution (10 Ϫ2 M) in H2O adjusted to pH 10.0 with 0.1 NaOH was diluted with aCSF to 2 ϫ 10 Ϫ6 M. The HO inhibitors chromium mesoporphyrin (CrMP) and tin protoporphyrin (SnPP), purchased from Frontier Scientific (Logan, UT), were protected from light at all times, and the cranial window was illuminated only during vessel diameter measurements. All other reagents were of analytical grade and were purchased from Sigma Chemical (St. Louis, MO).
Experimental design. After implantation of the cranial window, at least 30 min were allowed for exchange and equilibrium of fluid under the window with the subarachnoid fluid before experimentation was begun. The experimental design consisted of measurements of pial arterial diameter, mean arterial pressure, arterial blood gases, and pH.
Before and after induction of hypotension, aCSF for CO measurement was collected from beneath the cranial window into an amber vial, the internal standard 13 C 16 O (see below) was injected into the bottom of the vial, and the vial was immediately sealed with a rubberized Teflon-lined cap. The samples were heated in hot water bath (75°C), and CO production was determined using gas chromatography-mass spectrometry (GC-MS). GC-MS analysis of the headspace gas was performed on a Hewlett-Packard 5970 mass-selective ion detector interfaced to a Hewlett-Packard 5890A gas chromatograph. The separation of CO from other gases was carried out on a Varian 5A mole sieve capillary column (30 m; 0.32-mm inner diameter) with a linear temperature gradient from 35 to 65°C at 5°C/min. Helium was the carrier gas at a column head pressure of 4.0 lb./in. 2 . Aliquots (100 l) of the headspace gas were injected using a gas-tight syringe into the splitless injector with a temperature of 120°C. Mass-to-charge ratios (m/z) 28 and 29 corresponding to 12 C 16 O and  13 C 16 O, respectively, were recorded via selective ion monitoring. The amount of CO in samples was calculated from the ratio of peak areas of m/z 28 and 29. The results are expressed as picomoles of CO per milliliter of cerebrospinal fluid (CSF).
Dilatory effect of heme and involvement of HO. An initial set of experiments was performed to confirm the efficacy of CrMP in inhibiting HO (n ϭ 6). HLL (2 ϫ 10 Ϫ6 M) was placed under the window without and with CrMP(2 ϫ 10 Ϫ5 M). Pial arteriolar responses to hypotension. Hypotension was induced by the withdrawal of blood from the venous catheter until the arterial pressure dropped to 50% of its control level. To prevent clot formation in the withdrawn blood, we placed heparin in the syringe before commencing hemorrhage. After pial arteriolar diameter was measured for the hypotensive state, topical CrMP (2 ϫ 10 Ϫ5 M) or systemic SnPP (3 mg/kg iv) was administered to inhibit HO activity. Control piglets were treated identically except that no blood was withdrawn.
NO/PG clamp. We performed the same experiment with NO and prostacyclin held constant (NO/PG clamp). NO/PG clamp was accomplished by continuous topical application of N -nitro-L-arginine (L-NNA; 10 Ϫ3 M), sodium nitroprusside (SNP; 2 ϫ 10 Ϫ7 M), and iloprost (10 Ϫ10 M) and intravenous application of indomethacin (5 mg/kg).
To confirm prolonged inhibition of nitric oxide synthase (NOS) and cyclooxygenase (COX) and adequate NO/PG to allow dilation to CO in the presence of that inhibition, we topically applied CO in progressively increasing concentrations to pial arterioles, and the maximal pial arteriolar diameter reached over a 5-min period was recorded as the response to each dose. CO ascending dose-response curves were registered before and after no treatment or treatment with L-NNA (10 Ϫ3 M topically) and L-NNA plus SNP (2 ϫ 10 Ϫ7 M). In other piglets, the experimental approach described above for CO/L-NNA/ SNP was used, except that LNA was replaced by indomethacin (5 mg/kg) and SNP was replaced by iloprost (10 Ϫ10 M). Statistical analysis. Values are presented as means Ϯ SE. Results were subjected to a one-way ANOVA for repeated measures with Tukey's post hoc test to isolate differences between groups. A level of P Ͻ 0.05 was considered significant.
RESULTS
Topical application of the HO substrate HLL caused dilation of piglet cerebral arterioles that was blocked by the metal porphyrin inhibitor of HO, CrMP (Fig. 1) .
CrMP dilated pial arterioles in normotensive piglets (arterial pressure 64 Ϯ 4 mmHg) at 1 and 5 min with return to diameter not significantly different from control by 10 min (Fig. 2) . Figure 3 shows the effect of hypotension on pial arteriolar diameters and the effect of CrMP during hypotension on those diameters. Blood withdrawal produced rapid and sustained hypotension from 61 Ϯ 2 to 33 Ϯ 3, 35 Ϯ 3, 37 Ϯ 3, and 38 Ϯ 2 mmHg at 1, 5, 10, and 20 min, respectively. Concomitant with hypotension, pial arterioles dilated immediately (within 1 min) from an average of 75 to ϳ110 m that was sustained during 20 min of hypotension. Upon topical application of CrMP, arterial pressure changed minimally (40 Ϯ 4, 40 Ϯ 5, 36 Ϯ 7, and 38 Ϯ 6 mmHg at 1, 5, 10, and 20 min, respectively), but in contrast to normotension, pial arterioles constricted to normotensive diameters (Fig. 3) .
Hypotension markedly increased the CO concentration in CSF under the cranial window (Fig. 4) , concomitantly with the arteriolar dilation. That increase was reversed by systemic treatment with SnPP (Fig. 4) , which also constricted pial arterioles similarly to topical CrMP (Fig. 5) . Because NO and prostanoids could be involved in cerebrovascular dilation caused by CrMP or hypotension, we performed additional experiments in which both NO and prostacyclin were held constant (see MATERIALS AND METHODS). Results of the experiments conducted to confirm efficacy of the procedure used to clamp NO and prostacyclin constant while not changing responses to CO are shown in Figs. 6 and 7. Figure 6 shows that dilation to CO was abolished by L-NNA, and this blockage was effective for at least 1.5 h. SNP (2 ϫ 10 Ϫ7 M) restored the dilation to CO after inhibition of NOS. Figure 7 shows the effect of COX inhibition with indomethacin on vasodilation of pial arterioles to CO. Dilation to CO that was blocked by indomethacin treatment was restored by 10
The effect of CrMP on normotensive piglets with NO and prostacyclin held constant is shown in Fig. 8 . In normotensive pigs with NO and prostacyclin held constant, CrMP produced a transient dilation (Fig. 8 ) that was indistinguishable from intact piglets (Fig. 1) . Also, when prostacyclin and NO were held constant, CrMP caused vasoconstriction of pial arterioles of hypotensive pigs that was identical to that seen in piglets without NO/PG clamp (Fig. 9 ).
DISCUSSION
We found that 1) administration of CrMP blocked dilation to heme and caused transient dilation of pial arterioles in normotensive piglets; 2) hypotension increased CSF CO concentration; 3) in hypotensive piglets, CrMP and SnPP, which decreased CO production, constricted pial arterioles sufficiently to completely reverse hypotension-induced dilation; and 4) clamping both NO and prostacyclin constant had no effect on the response of pial arterioles to CrMP in either normotensive or hypotensive piglets. Therefore, the present data suggest that CO contributes to hypotension-induced cerebral vasodilation in the newborn.
CO is a physiologically significant messenger molecule in the brain and contributes to the regulation of cerebrovascular circulation. CO is a potent vasodilator of newborn pig cerebral arterioles in vivo (24) . CO contributes to dilation in response to excitatory amino acids, contributes to neuronal activity, and provides a modulatory vasodepressor influence that attenuates vasoconstrictor responses (6, 24, 38) There are at least two potential endogenous sources of CO production. A small amount may be from oxidation of organic molecules (31) , but the predominant source is from the degra- dation of heme. Results of topical application of HLL suggest endogenous HO can produce sufficient CO to dilate cerebral arterioles, and CrMP as administered in the present study blocks that production. Because no other heme metabolite has been shown to cause dilation and because CrMP did not affect dilatory responses to CO, it is reasonable to propose that HO-derived CO is the mediator of the dilatory effect of HLL.
Cellular CO production results from metabolism of heme by HO. In freshly isolated cerebral microvessels from newborn pigs, as in the intact brain, of the two known, highly catalytically active isoforms of HO, only HO-2 expression is detectable in vivo (28) . HO-2 is constitutively expressed and induced by few stimuli (25) , so expression of HO in the present experiments can be considered invariant.
CO production can be controlled by either regulation of substrate availability to HO or the effective catalytic activity of HO-2. HO-2 catalytic activity control mechanisms may be cell type and tissue specific. In neurons, HO-2 activity can be stimulated by casein kinase 2 (CK2)-catalyzed phosphorylation of serine-709 (4). In neurons, glutamatergic activation of HO-2 results from metabotropic glutamate receptor-induced Ca 2ϩ release, activation of protein kinase C (PKC), and CK2 phosphorylation (3). Conversely, in freshly isolated piglet cerebral microvessels, CO production is increased by ionotropic, but not metabotropic, glutamate receptor stimulation (18) . In addition, protein tyrosine kinase inhibition decreased and tyrosine phosphatase inhibition increased basal CO production and glutamate-stimulated CO production by piglet cerebral microvessels (18) . Treatment of the cerebral microvessels with phorbol ester to activate PKC, H-7 to inhibit PKC, or 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB) to inhibit CK2 did not increase HO-2 catalytic activity (18) .
Age-related differences in mechanisms involved in cerebrovascular regulation have been observed (37, 41) . CO induces cerebral arteriolar dilation in newborn pigs by activating largeconductance K Ca channels (14, 24) . Whether the apparently increased vasodilatory sensitivity to CO observed in newborn pig cerebrovascular circulation compared with adult cerebral arteries (1, 5, 17, 24) is due to age, species, or both remains uncertain. However, developmental differences seem plausible considering that low cerebrovascular sensitivity to CO is found in adult rats (1) and rabbits (5) , and relative contributions of paracrine mediators in control of cerebrovascular circulation appear to be age dependent. For example, in the newborn pig, contributions of prostanoids overshadow those of NO (41), whereas with age, the importance of NO increases to the point where the relative contributions of prostacyclin and NO are similar to the adult (2, 34, 36, 37, 41) . If COX is chronically inhibited in piglets, the involvement of NO is upregulated (40) . COX activity stimulates HO-2 (16) and CO inhibits NOS (13) , which could contribute to the reduced functional significance of NO and the increased importance of CO in the neonatal cerebrovascular circulation.
Rat gracilis muscle arteriole responses to CO are inhibited by blockers of K Ca channels (35) . When activated, K Ca channels cause hyperpolarization and a reduction in voltage-dependent Ca 2ϩ channel activity (15 sparks and strongly increases spark-to-STOC coupling (39) . CO may interact with other important paracrine mediators in control of cerebrovascular circulation during hypotension. Hypotensive hemorrhage stimulates the release of vascular prostanoids into cortical subarachnoid CSF concomitant with dilation of pial arterioles in anaesthetized newborn pigs (19) . Prostacyclin can cause dilation directly via increases in vascular smooth muscle cAMP (29) . Indomethacin, which blocks prostaglandin synthesis, reverses dilation of pial arterioles to hypotension (19) . Along with prostacyclin, NO is responsible for endothelium-derived relaxation of many arteries and for counteracting vasoconstrictor effects of endothelin and thromboxane A 2 (10, 11) . In newborn pigs, neurally mediated dilation (26) involves NO. CO dose dependently inhibits NO synthesis by rat renal arteries, although low concentrations of CO actually increase NO by causing release from a preformed pool (33) .
CO-induced dilation of newborn cerebral arterioles involves interaction with the cerebral prostanoid and NO systems (23) . NO and prostacyclin are obligate permissive enabling factors for CO-induced cerebrovascular dilation in newborn pigs. Inhibition of COX with indomethacin or inhibition of NOS with L-NNA blocks the dilatory responses of piglet cerebral arterioles to CO. Thus, in the piglet cerebrovascular circulation, glutamate-induced pial arteriolar dilation can be blocked by inhibiting either NOS (26) , which produces NO, or HO (30) , which produces CO because the necessary permissive NO is gone following NOS inhibition. Blockage of CO-induced dilation by indomethacin and L-NNA can be reversed with iloprost and/or SNP (present study and Ref. 21) .
Therefore, to investigate the role of CO in dilation to hypotension without the complication of increasing NO and prostacyclin, we clamped NO and prostacyclin constant by blocking COX and NOS but returning the products with SNP and iloprost. Under these conditions, the CO production could change but neither NO nor prostacyclin could. Nevertheless, the effects of HO inhibition were unaltered, suggesting that dilation did not involve hypotension-induced increases in NO and prostacyclin production. Furthermore, the transient dilation to CrMP in normotension persisted, suggesting increased NO resulting from reduced CO modulation of NOS did not cause the dilation.
In summary, this study demonstrates that HO-derived CO is an important component of cerebrovascular dilation in response to reduced perfusion pressure in the newborn pig. The study impacts importantly on the regulatory influence of the heme/HO/CO system on the cerebral vasculature.
